Perrigo Company is poised to divest its Latin American OTC business to private-equity firm Advent International as part of its ongoing self-care transformation plan.
This transaction, which is expected to close in the second half of this year, will see Advent acquire
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?